Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Janssen submits US FDA new drug application for simeprevir / sofosbuvir combination use

Editor's pick
Janssen press release
8 May 2014
Access to healthcare

UNITAID approves grants of $160 million, for hepatitis C, MDR-TB and malaria drugs

Editor's pick
UNITAID
7 May 2014
Hepatitis C transmission & prevention

UK - 'Eradicating hepatitis C is a realistic aim'

Editor's pick
Health Service Journal
6 May 2014
Hepatitis C treatment

Sustained response to treatment reduces fatigue in hepatitis C patients

News
6 May 2014
Pharmaceutical industry

Vertex ends hepatitis C investment as sales fall

Editor's pick
CNBC
2 May 2014
Hepatitis C treatment

Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4

News
2 May 2014
Hepatitis B

Hepatitis B a growing problem in UK prisons

Editor's pick
The Independent
1 May 2014
Elimination of hepatitis C

Eliminating Hepatitis C Within a Generation. What are you going to do about it?

Editor's pick
You Tube / Jon Derricott
30 April 2014
Pharmaceutical industry

Biotech’s Hard Bargain

Editor's pick
The New Yorker
24 April 2014
Hepatitis B

Anti-HBV antiretrovirals may help ward off HBV infection in MSM

Editor's pick
International AIDS Society
24 April 2014
Harm reduction

Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users

Editor's pick
Infectious Disease Special Edition
24 April 2014
Hepatitis C transmission & prevention

Studies investigate presence of hepatitis C virus among gay and bisexual men

Editor's pick
CATIE
24 April 2014
New & experimental hepatitis C treatment

Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence

News
23 April 2014
New & experimental hepatitis C treatment

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Editor's pick
AbbVie press release
23 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Hepatitis C treatment

Sofosbuvir for hepatitis C works well despite multiple negative predictive factors

News
23 April 2014
New & experimental hepatitis C treatment

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6

News
17 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
New & experimental hepatitis C treatment

England: Patients with end-stage liver disease caused by hepatitis C to get new drug

Editor's pick
The Guardian
17 April 2014
New & experimental hepatitis C treatment

BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks

News
17 April 2014
Hepatitis C treatment

Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease

News
16 April 2014
Hepatitis B

Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B

News
16 April 2014
New & experimental hepatitis C treatment

AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis

News
15 April 2014
New & experimental hepatitis C treatment

AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C

News
14 April 2014